| Management of chronic fatigue and muscle weakness |
| Support in cardiovascular health and energy metabolism |
| Adjunct in male infertility and sperm motility improvement |
| Antioxidant support in oxidative stress-related conditions |
Tablet
This fixed-dose combination provides dual benefits in type 2 diabetes management. Gliclazide, a sulfonylurea, stimulates insulin secretion from pancreatic beta cells, while Metformin, a biguanide, reduces hepatic glucose production and improves insulin sensitivity.
| Speciality | Endocrinology | Diabetology | General Medicine |
|---|---|
| Tags | Sulfonylurea | Biguanide | Type 2 Diabetes | Blood Sugar Control |
| Strength |
|
| Packing Size |
|